Kawai Y, Uneda K, Yamada T, et al
Past studies show there are positive and negative side effects from GLP-1 medications
Answer: Retatrutide is a triple agonist, meaning a single molecule engages the GLP-1, GIP, and glucagon receptors simultaneously, combining appetite suppression, improved glucose handling, and direct fat metabolism in one weekly dose
doi:doi:10.1161/JAHA.125.043373
November 3, 2025: Ozempic Interferes With Medical Imaging Tests, Study Finds A study has found that taking Ozempic and other GLP-1 receptor agonists can cause issues with medical imaging tests (like PET scans)
If safety and predictable results matter, pick an experienced dermatology clinic and get a proper consultation